We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:DFTX
​
​
logo

Definium Therapeutics (DFTX)

Nasdaq • DFTX • CA24477V1058

33.27Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 8.9% of free float sold short, 5.2 days to cover, cost to borrow 0.43%. Sign up for live short interest data.

Market Cap

4.47b USD | # 2625 in US

Volume

2.16m shares | 82.64m USD

Shares Outstanding

134.37m

Free Float Shares

93.42% | 125.52m

DB:MMQ0

News

DFTX key data

Definium Therapeutics (Nasdaq: DFTX) has a market capitalization of $4.47B. Last close $33.27 (as of 2026-11-09); 52-week range $10.46 to $49.70. ORTEX data as of 2026-10-22: short interest was 8.93% of free float, 5.2 days to cover and the average cost to borrow was 0.43%. Sign up for live short interest data.

  • DFTX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.